dc.date.accessioned2020-06-10T18:12:13Z
dc.date.available2020-06-10T18:12:13Z
dc.date.created2020-06-10T18:12:13Z
dc.date.issued2014
dc.identifierhttps://hdl.handle.net/20.500.12866/8049
dc.identifierhttps://doi.org/10.1002/pon.3372
dc.description.abstractObjective: This study aimed to study the comorbidity of common mental disorders (CMDs) and cancer, and the mental health treatment gap among community residents with active cancer, cancer survivors and cancer-free respondents in 13 high-income and 11 low-middle-income countries. Methods Data were derived from the World Mental Health Surveys (N = 66,387; n = 357 active cancer, n = 1373 cancer survivors, n = 64,657 cancer-free respondents). The World Health Organization/Composite International Diagnostic Interview was used in all surveys to estimate CMDs prevalence rates. Respondents were also asked about mental health service utilization in the preceding 12 months. Cancer status was ascertained by self-report of physician's diagnosis. Results Twelve-month prevalence rates of CMDs were higher among active cancer (18.4%, SE = 2.1) than cancer-free respondents (13.3%, SE = 0.2) adjusted for sociodemographic confounders and other lifetime chronic conditions (adjusted odds ratio (AOR) = 1.44, 95% CI 1.05-1.97). CMD rates among cancer survivors (14.6%, SE = 0.9) compared with cancer-free respondents did not differ significantly (AOR = 0.95, 95% CI 0.82-1.11). Similar patterns characterized high-income and low-middle-income countries. Of respondents with active cancer who had CMD in the preceding 12 months, 59% sought services for mental health problems (SE = 5.3). The pattern of service utilization among people with CMDs by cancer status (highest among persons with active cancer, lower among survivors and lowest among cancer-free respondents) was similar in high-income (64.0%, SE = 6.0; 41.2%, SE = 3.0; 35.6%, SE = 0.6) and low-middle-income countries (46.4%, SE = 11.0; 22.5%, SE = 9.1; 17.4%, SE = 0.7). Conclusions Community respondents with active cancer have higher CMD rates and high treatment gap. Comprehensive cancer care should consider both factors.
dc.languageeng
dc.publisherWiley
dc.relationPsycho-Oncology
dc.relation1099-1611
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectAdult
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectSocioeconomic Factors
dc.subjectepidemiology
dc.subjectDeveloped Countries
dc.subjectDeveloping Countries
dc.subjectmental health
dc.subjectincome
dc.subjecthuman
dc.subjectadult
dc.subjectfemale
dc.subjectmale
dc.subjectcomorbidity
dc.subjectmental disease
dc.subjectComorbidity
dc.subjectMental Health Services
dc.subjectmajor clinical study
dc.subjectprevalence
dc.subjectarticle
dc.subjectmorbidity
dc.subjectHealth Surveys
dc.subjectWorld Mental Health Surveys
dc.subjecthealth care utilization
dc.subjecthealth survey
dc.subjectNeoplasms
dc.subjectMental Disorders
dc.subjectmental health service
dc.subjectresident
dc.subjectcancer
dc.subjectoncology
dc.subjectWorld Health
dc.subjectSurvivors
dc.subjectcancer survivor
dc.subjecttreatment gap
dc.titleComorbidity of common mental disorders with cancer and their treatment gap: Findings from the World Mental Health Surveys
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución